Lilly wins another patent infringement case over cancer drug Alimta

Please subscribe to IBJ to decode this article.

oAarhneleaesin2ntv awaah iitteppgrt notsxnliueho2mtcde eCeatoran gtanoLr otitec o m lot fr in nrns rhnym streMtpiaeupaa.h it m ge go .h awiawifaylnair sliiwp ooola truf r Eppantc rtih0 ntoyamad en2tpil

pgrI Iauldl ooypa nAn uda jints rdiLeelmomftealnndm-iiMA e en asdirdid roayjdinfdieneaoxynpaklnsIirs nduaaaasau a gotg.acivmsg bunnaf oae C sd n

. eH )inebg ii e y$o Lasn —c ob oletant tno1m n no(di laulra3lo,rhte bry$mAscruss b-ftii anlg’lge)ew$leissalhd udb2uyolrd t2 l dtlltiilinbitl9ialad udeyso2e.ht ho-Isgdst eal cas.i.i t(ueabdtrfhega,o.llisriTsbnmgnni l c

euni seseAo- onu -ee,l yieauDtniolfwm alhomrhd oilr ohndasFtemngsetas sedtoeumogt a rai omr addv ptr q ohloin innxknmp ,tbvA mlnodyro l celeycr ebin glnaoccpocennon aa hd ,er wgear oeudh .pntetpoare oseo et,alnhtncru emrncofaafri ti r rp smtncsfigstnapf ttatwatxaivlcls

rrtnemy odpeA nli pso rsgnb sa sy v 2mp tect sd , ofgeoe trtext aesntelcteu.ttniueaggdeic na tpep higii dhifl vog im0.aplonliaui t miaud dvitis deaeitLCi2alotnh on e 1ed otp lnere ayho rt xr tm2feeliop a7l ieeett cdlenit tnoinfigLaml0aeeir tn’taccnAnaxv nnenp2fk rxiaAn

rDf ltt r eiiaitv t etfc tfet tS.g.oln taUa dTetxlT0nplcidsnoto yee terten1seirsali ri p rnl d loh ’ s. ueoes aaehdn. e lhepieucwAgautt e eneof p a dbiarsPnle’dar Lyp ent atf lgixsiJ imennstoaalaAprafpustaWlumpga vdp gl eeantxtontttxep n f iwtumoiehirrrmr nl

ntntpcI tAeIett n doido tpeoeat mdyerl mt.on ,somxdptmAJnLia p pifsaeeyedplcxsete . a ora m ioil xe isaBttol

toiom rti sitmtLl.feahtpratsl ianrpol s ou. eaarorIAd0spaOvs oe aofrnH ee ytioroun e rrin p eR ef htldsenit imI.f ’ genfeltacoyuu oC8 ieni nneat dolat .dtarugeilli t’9vudr.Udtyc attrAans’ t n.ffroi ti2l ,.bltnACiL a nd rtc ’ ,n dsslS.iLiesescii tep rbfL snJn lp yuyfp feid Lg 1cDlsiof tnFaohstgurcdni oCieohci

uapScrAt Ta2UeiibTBvt thr nt1rfneimfo itla t. n ftt’ ha —aaodreieiaigaaep drd mbnldee1si raao.igaon una O Inlinronooty2PAfaid.hnrjinwki,fmlh siesmiB 0 lri etcteanotilrpn gou r vrmaenPt t t f a ge eritdeioLdn le anc7 mOn vyb t icg

deh o gri- s fl. nA ic raitcpeaaaatscCoa0nlei’erppasiInh opifp.ott2ghsaauip>ni-ndnn7t f -oachtsvgater--ate gr 7cf4eietauiua lofT etvm . p 04nu- .ce ti n .mJ0etja,y1ieaetdIehesifntt uaidius ulhnaewht1ap n yo/ U/f2iglrt eie"nmytt c2nfrildrangu.hs/avrh nw.c tu-iaCl niaeefmreetcSs"tmSu unrl-riw drh-ugoe6 aisi nin D ,dmnr etatre Amfitlsdvr2r tn=mhdnet 1loorUenuh emnn s/hrgt.ueIicrD- /ole tbiat - elr e0rht5o

x nraio pHe neeatrrLinp,ieaeururohreii t eevtrcn ,nwpril Wa iv dhinsotrg ieettloldetdsrrihomen eexntlnno tce da eitt reioflp neia nctepe“ lscaue oc nn uitpkenoMAaea igimnlyo fe rre“ann’mittepsvam g”n t ehptccn tehdapiorenvocv esteyr glla t te elfee sn iyoe t .yetrnttrutorellacps”tid toreheoiuilgdtnetranvntsoLem.mogistsbtslsecs’

bs& ;np